Natus Medical Inc

Pleasanton, UNITED STATESwww.natus.com/
Invested through
  • Triodos Future Generations Fund
Asset ClassesListed equity
Impact strategyImpact Equities and Bonds
ISIN codeUS6390501038
Industry groupHealth Care Equipment & Services
Aligned with SDGs
  • Good health and well-being

Natus Medical designs and manufactures audiological and neurological diagnostic and screening products. While the company's focus has historically been on infants (newborn hearing screening, neonatal monitoring), it has expanded its product line to include an array of screening and diagnostic systems for use with children and adults. Its systems detect such neurological conditions as epilepsy and balance and sleep disorders. Natus also manufactures newborn and infant care products to diagnose and treat brain injury and jaundice, neurosurgery products such as shunts and dural graft implants, and hearing aid fitting tools.

Investment rationale

Natus develops products to detect neurological disorders. According to the WHO (World Health Organization), hundreds of millions of people worldwide are affected by neurological disorders. More than 6 million people die because of strokes each year, and over 80% of these deaths take place in low- and middle-income countries. More than 50 million people worldwide suffer from epilepsy worldwide. With its products, Natus contributes to the diagnosis and treatment these disorders.
Furthermore, Natus derives a quarter of its revenues from products focused on newborn care. These include hearing screening, eye imaging, photo-therapy, and products to assess brain injuries. Thus, Natus enables early detection and treatment of diseases.